**Author details**

Mehmet Sait Bakir Division of Gyneacologic Oncology, Department of Gyneacology Obstetrics, Akdeniz University, Antalya, Turkey

\*Address all correspondence to: sabakcil@gmail.com

© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**167**

3652025]

[PubMed: 14984936]

[7] Canlorbe G, Bendifallah S,

Oncology. 2016;**23**(1):171-177

Laas E, et al. Tumor size, an additional prognostic factor to include in low-risk endometrial cancer: Results of a French multicenter study. Annals of Surgical

*Brachytherapy in Endometrial Cancer*

[Accessed: 03 April 2015]

[3] National Cancer Institute. Endometrial Cancer Treatment. Physician Data Query (PDQ ). 2015. Available from: http://www.cancer. gov/cancertopics/pdq/treatment/ endometrial/healthprofessional [Accessed: 01 April 2015]

**References**

*DOI: http://dx.doi.org/10.5772/intechopen.92703*

[1] WHO. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. 2012. Available from: http://globocan.iarc. fr/Pages/fact\_sheets\_population.aspx

[8] Creutzberg CL, van Putten WL, Koper PC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: Multicentre randomised trial. PORTEC study group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet. 2000;**355**:1404-1411. [PubMed:

[9] Colombo N, Creutzberg C, Amant F, Bosse T, González-Martín A, Ledermann J, et al. ESMO-ESGO-ESTRO endometrial consensus conference working group. International Journal of Gynecological

Cancer. 2016;**26**(1):2-30. DOI: 10.1097/IGC.0000000000000609.

[10] Creutzberg CL, van Putten WL, Koper PC, et al. The morbidity of treatment for patients with stage I endometrial cancer: Results from a randomized trial. International Journal of Radiation Oncology, Biology, Physics. 2001;**51**:1246-1255. [PubMed: 11728684]

[11] Nout RA, van de Poll-Franse LV, Lybeert ML, et al. Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial. Journal of Clinical Oncology. 2011;**29**:1692-1700. [PubMed:

[12] Harkenrider MM, Grover S, Erickson BA, et al. Vaginal brachytherapy for postoperative endometrial cancer: 2014 survey of the American brachytherapy society. Brachytherapy. 2016;**15**(1):23-29

[13] Tanderup K, Lindegaard JC. Multi-channel intracavitary vaginal brachytherapy using three-dimensional optimization of source geometry.

PMID:26645990

21444867]

10791524]

[2] Lee NK, Cheung MK, Shin JY, et al. Prognostic factors for uterine cancer in reproductive-aged women. Obstetrics and Gynecology. 2007;**109**:655Y662

[4] Aalders J, Abeler V, Kolstad P, et al. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: Clinical and histopathologic study of 540 patients. Obstetrics and Gynecology. 1980;**56**:419-427. [PubMed: 6999399]

[5] Creasman WT, Morrow CP, Bundy BN, et al. Surgical pathologic spread patterns of endometrial cancer. A gynecologic oncology group study. Cancer. 1987;**60**:2035-2041. [PubMed:

[6] Keys HM, Roberts JA, Brunetto VL, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: A gynecologic oncology group study. Gynecologic Oncology. 2004;**92**:744-751. *Brachytherapy in Endometrial Cancer DOI: http://dx.doi.org/10.5772/intechopen.92703*
